Literature DB >> 3934453

Protective adaptation of low serum triiodothyronine in patients with chronic renal failure.

V S Lim, M J Flanigan, D C Zavala, R M Freeman.   

Abstract

Low serum triiodothyronine (T3) concentration is frequently found in patients with chronic renal failure (CRF). To test the hypothesis that this may serve to minimize protein catabolism in these patients, we measured nitrogen balance (Nb) in seven CRF and four control subjects in the basal state and when serum T3 concentration was elevated by L-triiodothyronine (LT3) and suppressed by sodium ipodate administration. In the basal state, both the controls and the CRF patients were in positive Nb, 0.02 +/- 0.51 and 0.58 +/- 0.34 g/day, respectively. During LT3 administration, Nb decreased to -0.80 +/- 0.39 g/day in the CRF patients (P less than 0.01), but remained positive, 0.22 +/- 0.67 g/day, in the controls. There was a significant negative correlation between serum T3 concentration and Nb in the CRF patients (r = -0.63, P less than 0.005), but not in the controls. Furthermore, urea nitrogen generation rate, calculated from urea kinetics, increased from a baseline of 4.6 +/- 0.55 to 6.0 +/- 0.50 mg/min during LT3 administration in the CRF patients (P less than 0.01). Sodium ipodate, which significantly lowered serum T3 concentrations, had little effect on nitrogen metabolism in the controls and the CRF patients. These data support the concept that low serum T3 concentrations may confer a protective effect on CRF patients regarding protein-nitrogen conservation and provide a rationale for not correcting such deficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3934453     DOI: 10.1038/ki.1985.162

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  Hormonal regulation of energy-protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes.

Authors:  Manish Suneja; Daryl J Murry; John B Stokes; Victoria S Lim
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

3.  Prevalence of Subclinical Hypothyroidism in Patients with End-Stage Renal Disease and the Role of Serum Albumin: A Cross-Sectional Study from South India.

Authors:  Ghanshyam Palamaner Subash Shantha; Anita Ashok Kumar; Viraj Bhise; Rohit Khanna; Kamesh Sivagnanam; Kuyilan Karai Subramanian
Journal:  Cardiorenal Med       Date:  2011-10-12       Impact factor: 2.041

4.  Comparison between serum free triiodothyronine levels and body fluid distribution in hemodialysis patients.

Authors:  Osamu Saito; Takako Saito; Koshi Ueno; Takeshi Shiraishi; Takanori Kikuchi; Hisashi Yamamoto; Tetsu Akimoto; Yasuhiro Ando; Shigeaki Muto; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2012-06-08       Impact factor: 2.801

5.  New Insights toward the Acute Non-Thyroidal Illness Syndrome.

Authors:  Simone Magagnin Wajner; Ana Luiza Maia
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-26       Impact factor: 5.555

6.  Thyroid hormone receptor binding to DNA and T3-dependent transcriptional activation are inhibited by uremic toxins.

Authors:  Guilherme M Santos; Carlos J Pantoja; Aluízio Costa E Silva; Maria C Rodrigues; Ralff C Ribeiro; Luiz A Simeoni; Noureddine Lomri; Francisco Ar Neves
Journal:  Nucl Recept       Date:  2005-04-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.